Problems viewing this newsletter? View it in your browser >

Our Post-CROI 2016 Webinar Series Continues

March 21, 2016

Dear Advocates,

Reminder, our post-CROI 2016 webinar series continues this Thursday, March 24 at 10am EDT with Long-Acting Injectable Antiretrovirals for Treatment and Prevention (the US is now on Daylight Savings Time—check for the time in your area). 

Heard about a “tail” for long-acting injectables and want to know more? Interested in the timeline for when people with HIV might have injectable drug options for treatment? Wondering how people felt about getting an injection for PrEP?
Join fellow advocates, and researchers David Margolis of ViiV Healthcare and Marty Markowitz of the Aaron Diamond AIDS Research Center to talk about long-acting injectable antiretrovirals for treatment and prevention.

Register here.

Slides and audio from previous webinars in the series are also available:

Harnessing Antibodies for HIV Prevention and Treatment
John Mascola from the NIH Vaccine Research Center expanded on work he presented at his CROI plenary

Exploring Dapivirine Ring Results
In the first webinar of our post-CROI webinar series, Jared Baeten (MTN) and Zeda Rosenberg (IPM) spoke about the dapivirine ring trial results announced at the conference.

If you have any questions, please be in touch at!



A FRESH Look at Basic HIV Cure ResearchToday we have a FRESH look at basic HIV cure research. Our blog is where biomedical HIV prevention advocacy has its say about the latest findings, biggest challenges and most exciting successes in our collective work.


Forward This IssueDo you know someone who might be interested in receiving this newsletter?
Forward > 

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
Unsubscribe > 

Contact Us T: +1 212 796 6423